Dermatology News

The first patient has been enrolled in a phase 2 clinical trial of D-MNA for the treatment of basal cell carcinoma, Medicus Pharma announced in a press release.

Attempts to curtail prior authorizations for patients insured by Medicare Advantage plans have failed in back-to-back legislative sessions in 2019 and 2021, but a new bill has some experts hopeful that the third time is a charm.

Two randomized phase 3 trials of pembrolizumab — one in lung cancer and one in skin cancer — have been discontinued due to lack of efficacy, according to the agent’s manufacturer.

It has been 9 months since the FDA released recommended changes to the iPledge Risk Evaluation and Mitigation Strategy, and providers are growing increasingly frustrated at a perceived lack of transparency and implementation plan.

A novel therapeutic approach stimulated new and existing T-cell responses among patients with melanoma or non-small cell lung cancer, according to results of a phase 1 trial.

Children with diverse skin types with atopic dermatitis-prone skin did not experience any adverse events when using a sunscreen formulated with antioxidants, according to a study.

Since 1993, the American Academy of Dermatology has held a unique weeklong summer camp experience for kids aged 8 to 16 years with chronic skin conditions.

A panel of experts shared consensus statements on how to best manage adult acne, according to a study.

A topical cream containing cannabis “significantly reduced the severity of itching” symptoms in patients with chronic kidney disease-related pruritus, according to published data.

Gaining weight can raise the risk for atopic dermatitis and possibly other immune-mediated skin diseases in children, whereas losing weight can reduce this risk, according to a study.